Precision BioSciences, Inc. - stock earnings
DTIL Upcoming estimated earnings
| Date | Actual / Estimated EPS | Low Revenue | Actual / Estimated Revenue | High Revenue |
|---|---|---|---|---|
| May 7, 2024 BeforeMarket | - / -1.9339000000 | - | - / 6.6 million | - |
DTIL Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q3 | -8.1 million USD | 13.1 million USD |
| 2023Q2 | -11.9 million USD | 19.8 million USD |
| 2023Q1 | -23.6 million USD | 8.8 million USD |
| 2022Q4 | -36.5 million USD | 10.6 million USD |
| 2022Q3 | -25.0 million USD | 7.4 million USD |
| 2022Q2 | -32.5 million USD | 3.8 million USD |
| 2022Q1 | -29.0 million USD | 3.3 million USD |
| 2021Q4 | -22.3 million USD | 6.3 million USD |
| 2021Q3 | -11.3 million USD | 24.0 million USD |
| 2021Q2 | 21.7 million USD | 68.8 million USD |
| 2021Q1 | -18.7 million USD | 16.3 million USD |
| 2020Q4 | -23.5 million USD | 8.8 million USD |
| 2020Q3 | -26.0 million USD | 7.4 million USD |
| 2020Q2 | -32.7 million USD | 1.1 million USD |
| 2020Q1 | -26.8 million USD | 7.0 million USD |
| 2019Q4 | -20.9 million USD | 6.5 million USD |
| 2019Q3 | -20.7 million USD | 4.9 million USD |
| 2019Q2 | -19.4 million USD | 5.4 million USD |
| 2019Q1 | -31.8 million USD | 5.5 million USD |
| 2018Q4 | -15.4 million USD | 4.9 million USD |
| 2018Q3 | -9.8 million USD | 2.5 million USD |
| 2018Q2 | -11.8 million USD | 1.9 million USD |
| 2018Q1 | -9.0 million USD | 1.5 million USD |
| 2017Q4 | -7.4 million USD | 1.5 million USD |
DTIL Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -73.5 million USD | 52.3 million USD |
| 2022 | -122.9 million USD | 25.1 million USD |
| 2021 | -30.9 million USD | 115.5 million USD |
| 2020 | -109.0 million USD | 24.3 million USD |
| 2019 | -83.3 million USD | 22.2 million USD |
| 2018 | -46.0 million USD | 10.9 million USD |
| 2017 | -21.1 million USD | 6.5 million USD |
| 2016 | -8.3 million USD | 7.0 million USD |
DTIL
Price: $11.17
52 week price:
Earnings Per Share: -332.12 USD
P/E Ratio: -13.94
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 459600
Market Capitalization: 94.0 million